Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 83 (20), 7795-9

Differential Effects of Transforming Growth Factor Type Beta on the Growth and Function of Adrenocortical Cells in Vitro

Differential Effects of Transforming Growth Factor Type Beta on the Growth and Function of Adrenocortical Cells in Vitro

M Hotta et al. Proc Natl Acad Sci U S A.


Transforming growth factor type beta (TGF-beta) suppresses basal as well as corticotropin (ACTH)-stimulated steroid formation by bovine adrenocortical cells in culture. The effect is dose dependent and is not accompanied by any change in adrenocortical cell growth. The minimum effective dose of TGF-beta is 4 X 10(-13) M (10 pg/ml), and maximal inhibition is observed at a concentration of 4 X 10(-11) M (1 ng/ml). A 16- to 20-hr incubation with TGF-beta is required to decrease steroidogenesis, and 12-18 hr are required before cells treated with TGF-beta recover complete responsiveness to corticotropin. Increases in cAMP mediated by corticotropin, forskolin, and isobutylmethylxanthine are not modified by the addition of TGF-beta; thus adenylate cyclase activity is unaffected by TGF-beta. Although TGF-beta inhibits the formation of all of the delta 4-steroids measured (including cortisol, corticosterone, aldosterone, and androstenedione), its effect can be completely reversed by the addition of 25-hydroxycholesterol, pregnenolone, or progesterone to the cells. In contrast, the addition of low density lipoprotein has no effect suggesting that TGF-beta targets the conversion of cholesterol precursors to cholesterol. The results demonstrate a highly potent effect of TGF-beta on the differentiated function of the adrenocortical cell. The inhibition of steroidogenesis can be dissociated from any effect on cell proliferation, and it occurs distal to the formation of cAMP but proximal to the formation of cholesterol. The results suggest that in the adrenal, TGF-beta or TGF-beta-like proteins may be playing an important role in modifying the differentiated state of the adrenocortical cell.

Similar articles

See all similar articles

Cited by 11 PubMed Central articles

  • Corticosteroids for Treating Sepsis in Children and Adults
    D Annane et al. Cochrane Database Syst Rev 12 (12), CD002243. PMID 31808551. - Review
    Moderate-certainty evidence indicates that corticosteroids probably reduce 28-day and hospital mortality among patients with sepsis. Corticosteroids result in large reduc …
  • Transforming Growth factor-β1 and Diabetic Nephropathy
    AS Chang et al. Am J Physiol Renal Physiol 310 (8), F689-F696. PMID 26719364. - Review
    Transforming growth factor-β1 (TGF-β1) is established to be involved in the pathogenesis of diabetic nephropathy. The diabetic milieu enhances oxidative stress and induce …
  • Corticosteroids for Treating Sepsis
    D Annane et al. Cochrane Database Syst Rev 2015 (12), CD002243. PMID 26633262. - Review
    Overall, low-quality evidence indicates that corticosteroids reduce mortality among patients with sepsis. Moderate-quality evidence suggests that a long course of low-dos …
  • The Role of Transforming Growth Factor β1 in the Regulation of Blood Pressure
    K Matsuki et al. Curr Hypertens Rev 10 (4), 223-38. PMID 25801626. - Review
    Although human association studies suggest a link between polymorphisms in the gene encoding transforming growth factor (TGF) β1 and differing blood pressure levels, a ca …
  • Transforming Growth Factor beta1 and Aldosterone
    K Matsuki et al. Curr Opin Nephrol Hypertens 24 (2), 139-44. PMID 25587902. - Review
    These results identify TGFbeta signalling as an important counterregulatory system against aldosterone. Understanding the molecular mechanisms for the suppressive effects …
See all "Cited by" articles


    1. Ann Surg. 1975 Mar;181(3):325-32 - PubMed
    1. J Biol Chem. 1984 Aug 10;259(15):9756-61 - PubMed
    1. J Clin Invest. 1977 Aug;60(2):342-52 - PubMed
    1. Ann Surg. 1977 Jul;186(1):29-33 - PubMed
    1. Proc Natl Acad Sci U S A. 1978 Aug;75(8):4001-5 - PubMed

Publication types

MeSH terms

LinkOut - more resources